-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tn1SpJk4Jt9aPAA7LascL+vKy/Wv1OThQrigzuVvKngVIFsGIaUWvXDs4b8xtVf+ ++Ahd+5sipu/2mx0Xdw2TA== 0000728889-99-000018.txt : 19990215 0000728889-99-000018.hdr.sgml : 19990215 ACCESSION NUMBER: 0000728889-99-000018 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000946428 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061387931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-45017 FILM NUMBER: 99534887 BUSINESS ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 BUSINESS PHONE: 9146942285 MAIL ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 FORMER COMPANY: FORMER CONFORMED NAME: OSTECH INC DATE OF NAME CHANGE: 19950608 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER MANAGEMENT CORP CENTRAL INDEX KEY: 0000728889 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: TWO WORLD TRADE CENTER STREET 2: 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10048-0203 BUSINESS PHONE: 212-323-02 MAIL ADDRESS: STREET 1: TWO WORLD TRADE CENTER STREET 2: 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10048-0203 SC 13G/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2) Norland Medical Systems - ------------------------------------------------------------------------------ (Name of Issuer) Common Stock - ------------------------------------------------------------------------------ (Title of Class of Securities) 656031101 - ----------------------------------------------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) Page 1 of 7 Pages CUSIP No.656031101 13G Page 2 of 7 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR IRS IDENTIFICATION NO. OF ABOVE PERSON OppenheimerFunds, Inc. I.R.S. No. 13-2527171 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* A ---- B X ---- - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Colorado - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER: 0 SHARES --------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER: 0 OWNED BY --------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER:0 REPORTING --------------------------------------------------------------- PERSONAL 8 SHARED DISPOSITIVE POWER: 0 WITH --------------------------------------------------------------- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IA - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 7 Pages CUSIP No.656031101 13G Page 3 of 7 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR IRS IDENTIFICATION NO. OF ABOVE PERSON Oppenheimer Discovery Fund I.R.S. No. 22-2725700 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* A ---- B X ---- - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Colorado - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER: 0 SHARES --------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER: 0 OWNED BY --------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER:0 REPORTING --------------------------------------------------------------- PERSONAL 8 SHARED DISPOSITIVE POWER: 0 WITH --------------------------------------------------------------- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IV - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 3 of 7 Pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Item 1(a) Name of Issuer: Norland Medical Systems, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 106 Corporate Park Drive Suite 106 White Plains, NY 10604 Item 2(a) Name of Person Filing: OppenheimerFunds, Inc. Item 2(b) Address of Principal Business Office: Two World Trade Center, Suite 3400 New York, New York 10048-0203 Item 2(c) Citizenship: Inapplicable Item 2(d) Title of Class of Securities: Item 2(e) CUSIP Number: 656031101 Item 3(e) X Investment Adviser registered under Section 203 of the --- Investment Advisers Act of 1940 Item 4(a) Amount Beneficially Owned 0 shares Item 4(b) Percent of Class: 0% Item 4(c)(i) Sole Power to vote or to direct the vote - 0 Item 4(c)(ii) Shared power to vote or to direct the vote - 0 Item 4(c)(iii) Sole power to dispose or to direct the disposition of - 0 Item 4(c)(iv) Shared power to dispose or to direct the disposition of - 0 shares Page 4 of 7 Pages Item 5 Ownership to Five Percent or Less of a Class: -------------------------------------------- If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following: X Item 6 Ownership of More than Five Percent on Behalf of Another Person: ------------------------------------------------------------ Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: -------------------------------------------------------------- Inapplicable Item 8 Identification and Classification of Members of the Group: --------------------------------------------------------- Inapplicable Item 9 Notice of Dissolution of Group: ------------------------------ Inapplicable Item 10 Certification: ------------- By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 11, 1999 /s/ Merryl Hoffman Signature: ______________________________________ Name/Title: Merryl Hoffman, Vice President Page 5 of 7 Pages EXHIBIT A --------- The Board of Directors or Trustees of the registered investment companies managed by OppenheimerFunds, Inc. ("OFI") and owning shares of the issuer can direct the disposition of dividends received by such funds and can dispose of such securities. Additionally, OFI shares the power to dispose of such securities with the Board of Directors or Trustees of such funds; however, the Board of Directors or Trustees of such fund has delegated these responsibilities to OFI as the fund's investment advisor under its investment advisory agreement. OFI has an interest relating to five (5%) percent or more of such securities as disclosed on Page 2 hereof, by virtue of the interest of five percent (5%) or more of such securities by Oppenheime Fund, as disclosed on pages 3 and 4 hereof. OFI disclaims ownership of such securities, except as expressly stated herein. Page 6 of 7 Pages EXHIBIT B --------- The undersigned investment company hereby acknowledges and agrees that a report on Schedule 13G being filed by OppenheimerFunds, Inc. on or about the date hereof, relating to the preferred stock of Norland Medical Systems, Inc. is filed on behalf of the undersigned. Dated: February 11, 1999 Oppenheimer Discovery Fund /s/ Robert G. Zack By:______________________________________ Robert G. Zack Assistant Secretary Page 7 of 7 Pages -----END PRIVACY-ENHANCED MESSAGE-----